Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
S Afr Med J ; 108(6): 506-510, 2018 May 25.
Article in English | MEDLINE | ID: mdl-30004332

ABSTRACT

BACKGROUND: Ureteral stenting is generally a theatre-based procedure that requires a multidisciplinary team and on-table imaging. Limited hospital bed numbers and theatre time in our centre in Cape Town, South Africa, have led us to explore an alternative approach. OBJECTIVES: To see whether outpatient insertion of ureteric stents under local anaesthesia without fluoroscopy was a possible and acceptable alternative to theatre-based ureteral stenting. METHODS: Ureteral stenting (double-J stents and ureteric catheters) was performed with flexible cystoscopy under local anaesthesia and chemoprophylaxis, but without fluoroscopic guidance, in an outpatient setting. Every patient had an abdominal radiograph and an ultrasound scan of the kidney after the procedure to confirm stent position. RESULTS: Three hundred and sixteen procedures (276 double-J stents and 40 ureteric catheters) were performed in 161 men and 155 women. The overall success rate for the procedures was 85.4%, independent of gender (p=0.87), age (p=0.13), type of device inserted (p=0.81) or unilateral/bilateral nature of the procedure (p=1.0). Procedures with a successful outcome were performed in a significantly (p<0.0001) shorter median time (10 minutes (interquartile range (IQR) 5 - 15)) than failed procedures (20 minutes (IQR 10 - 30)). Patients with a pain score of >5 experienced a significantly (p=0.02) greater proportion of failure (27.3%) than patients with a pain score of ≤5 (12.5%). Difficulties were encountered in 23.7% of procedures, with a significantly higher proportion being registered in failed interventions compared with successful ones (82.6% v. 13.7%; p<0.0001). CONCLUSIONS: The procedure was easily mastered and technically simple, and represents savings in cost, time and human resources in our setting.

2.
Transpl Infect Dis ; 9(1): 62-5, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17313477

ABSTRACT

Only localized cases of Mycobacterium chelonae osteomyelitis have been reported. In this article, a 55-year-old immunosuppressed man with M. chelonae osteomyelitis and multiple spinal and extra-spinal involvement is presented. The patient had nodule-pustular skin lesions, spondylodiscitis at multiple levels, and osteolytic lesions at extra-spinal locations. Biopsy and cultures of the osseous lesions showed M. chelonae osteomyelitis. The patient started antimycobacterial chemotherapy with ciprofloxacin and clarithromycin. Progressive cervical kyphosis associated with anterior wedged deformity of the C5 vertebra and posterior C5-C6 spondylolisthesis resulted in compression of the spinal cord and neurological impairment. The patient underwent anterior decompression and C4-C6 arthrodesis using a titanium mesh cage and cervical plate. About 15 months after the initiation of chemotherapy and 5 months after surgery, the patient was pain free, with significant improvement of his neurological function. In the presence of immunosuppression, the physician should be alert for unusual or opportunistic pathogens of osteomyelitis. Long-term antimicrobial chemotherapy and surgical intervention is the cornerstone of successful treatment of multifocal bone M. chelonae infection.


Subject(s)
Discitis/etiology , Kidney Transplantation/adverse effects , Mycobacterium Infections, Nontuberculous/etiology , Mycobacterium chelonae , Osteomyelitis/etiology , Postoperative Complications , Tuberculosis, Spinal/etiology , Anti-Infective Agents/therapeutic use , Cervical Vertebrae/pathology , Ciprofloxacin/therapeutic use , Clarithromycin/therapeutic use , Graft Rejection/prevention & control , Humans , Immunosuppressive Agents/administration & dosage , Kyphosis/etiology , Male , Middle Aged , Risk Factors
3.
Exp Clin Endocrinol Diabetes ; 111(6): 370-3, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14520605

ABSTRACT

The effect of acute repaglinide administration (2 mg) on postprandial glycaemia and lipaemia has been examined in 20 subjects with type 2 diabetes mellitus. Each subject received in the morning, after a 12 to 14 h fast, a standard mixed meal (total energy 783 kcal), preceded by one tablet of 2 mg repaglinide or placebo. Chylomicrons and chylomicron-deficient plasma were prepared by ultracentrifugation. Triglyceride levels in CM fraction (CM-triglycerides) in total plasma as well as in CM-deficient plasma (non-CM-triglycerides) were determined. A significant reduction in postprandial glycaemia was observed after repaglinide administration compared to placebo ( p < 0.001). Plasma concentrations of total triglycerides, CM-triglycerides, non-CM-triglycerides, free fatty acids and the other plasma lipids measured, were not significantly different between the two phases of the study. It is concluded that, in contrast to sulphonylureas, acute repaglinide administration does not improve postprandial lipaemia in patients with type 2 diabetes.


Subject(s)
Carbamates/therapeutic use , Diabetes Mellitus, Type 2/drug therapy , Hyperlipidemias/blood , Piperidines/therapeutic use , Analysis of Variance , Blood Glucose/metabolism , C-Peptide/blood , Cholesterol/blood , Diabetes Mellitus, Type 2/blood , Fatty Acids, Nonesterified/blood , Glycated Hemoglobin/metabolism , Humans , Hyperlipidemias/drug therapy , Hypoglycemic Agents/therapeutic use , Insulin/blood , Kinetics , Postprandial Period , Triglycerides/blood
4.
Antimicrob Agents Chemother ; 43(3): 714-6, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10049299

ABSTRACT

A biodegradable polymer of DL-dilactide that facilitates release of ciprofloxacin or pefloxacin at levels exceeding MICs for the causative microorganisms of chronic osteomyelitis is described. Duration and peak of release were found to depend on the molecular weight of the polymer. Its characteristics make it promising for treating chronic bone infections.


Subject(s)
Anti-Infective Agents/chemistry , Lactic Acid , Polymers , Anti-Infective Agents/administration & dosage , Ciprofloxacin/administration & dosage , Ciprofloxacin/chemistry , Dioxanes/chemistry , Drug Carriers , Lactic Acid/chemistry , Molecular Weight , Pefloxacin/administration & dosage , Pefloxacin/chemistry , Polyesters , Polymers/chemistry , Solubility
SELECTION OF CITATIONS
SEARCH DETAIL
...